|
Mr. Kureshy has 30 years of entrepreneurial leadership experience in the healthcare industry beginning in R&D and advancing to general management where he has led three entrepreneurial organizations from start-up through market introduction and financial success. Previously, Mr. Kureshy served as President and CEO of Sequenom, Inc., President of Behring Diagnostics and PB Diagnostics where he has set up the infrastructure to design, develop, manufacture and market platform technologies in the area of chemistry, immunoassays and DNA analysis. Mr. Kureshy holds undergraduate degrees in physics, chemistry, mathematics and engineering and has completed graduate engineering studies. He was awarded a MBA from Southern Methodist University. | 